Lataa...
Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical In Vivo Models
Patients with pancreatic ductal adenocarcinoma have a dismall prognosis because at the time of diagnosis, in the vast majority of patients the tumor has already disseminated to distant organs and the therapeutic benefit of approved agents such as gemcitabine is limited. Therefore, the identification...
Tallennettuna:
| Julkaisussa: | Cancer Genomics Proteomics |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
International Institute of Anticancer Research
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885366/ https://ncbi.nlm.nih.gov/pubmed/31659100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20149 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|